Instrument Inactif

Gouvernance InMed Pharmaceuticals Inc Canadian Securities Exchange

IN

CA4576371062

Recherche biotechnologique et médicale

Comité Exécutif: InMed Pharmaceuticals Inc

Dirigeant

Fonctions occupéesDepuis

Eric Adams

63 ans

Chief Executive Officer	16/06/2016
President	16/06/2016

Eric Hsu

56 ans

Chief Tech/Sci/R&D Officer

13/03/2018

Michael Woudenberg

57 ans

Chief Operating Officer

15/07/2022

Gerard Griffin

Sales & Marketing

01/02/2022

Colin Clancy

Investor Relations Contact	-
Public Communications Contact	-

Jonathan Tegge

36 ans

Comptroller/Controller/Auditor

12/12/2022

Netta Jagpal

53 ans

Director of Finance/CFO	20/02/2024
Corporate Secretary	20/02/2024

Composition du Conseil d'Administration: InMed Pharmaceuticals Inc

Administrateur

ComitésDepuis

Andrew Hull

63 ans

Audit Committee
Compensation Committee
Governance Committee Chair	10/02/2025
Nominating Committee Chair	10/02/2025

Nicole Lemerond

50 ans

Audit Committee	04/08/2023
Governance Committee	04/08/2023
Nominating Committee	04/08/2023
Compensation Committee Chair	04/08/2023

Neil Klompas

54 ans

Audit Committee Chair

22/07/2024

John Bathery

57 ans

Director/Board Member

14/10/2025

Eric Adams

63 ans

Director/Board Member

16/06/2016

Anciens Dirigeants et Administrateurs: InMed Pharmaceuticals Inc

Insider

Fonctions occupées

DepuisJusqu'au

Bryan Baldasare

Director/Board Member	12/05/2022	17/12/2025
Independent Dir/Board Member	12/05/2022	17/12/2025

Janet Grove

Director/Board Member	11/02/2022	10/02/2025
Independent Dir/Board Member	11/02/2022	10/02/2025

Alexandra Mancini

General Counsel

31/10/2016

30/06/2024

Garner William

Director/Board Member	01/07/2016	-
Chairman	01/07/2016	15/12/2022
Independent Dir/Board Member	01/07/2016	15/12/2022

Brenda Edwards

Director of Finance/CFO

01/04/2022

20/11/2022

Adam Cutler

Director/Board Member	23/11/2015	08/08/2022
Independent Dir/Board Member	23/11/2015	08/08/2022

Bruce Colwill

Director of Finance/CFO

09/08/2019

31/03/2022

Catherine A. Sazdanoff

Director/Board Member	01/07/2019	11/02/2022
Independent Dir/Board Member	-	11/02/2022

Sarah Li

Comptroller/Controller/Auditor

01/01/2020

Martin Bott

Director/Board Member	13/01/2017	31/08/2019
Independent Dir/Board Member	13/01/2017	31/08/2019

Jeffrey Charpentier

Director of Finance/CFO	15/12/2016	09/08/2019
Corporate Secretary	15/12/2016	09/08/2019

Joshua Blacher

Corporate Officer/Principal

01/04/2018

01/08/2019

Sazzad Hossain

Director/Board Member	31/03/2015	12/09/2016
Chief Tech/Sci/R&D Officer	19/05/1981	11/01/2019
Founder	19/05/1981	11/01/2019

Terese Gieselman

Director of Finance/CFO

27/06/2011

15/12/2016

Stephen Tong

Director/Board Member	03/07/2013	13/06/2016
Independent Dir/Board Member	24/06/2013	13/06/2016

Kevin Puil

Director/Board Member

02/03/2015

27/08/2015

Paul Brennan

Director/Board Member	27/08/2015	-
Chief Executive Officer	-	-
President	-	-

Ado Mohammed

Chief Tech/Sci/R&D Officer	04/03/2015	-
Corporate Officer/Principal	-	-

Tarek S. Mansour

Director/Board Member

02/03/2015

Paul Chow

Director/Board Member	18/01/2011	03/07/2013
Independent Dir/Board Member	17/01/2011	03/07/2013

Matthew Dion

Chairman	26/11/2006	11/01/2012
President	26/11/2006	29/10/2010

Robert Dzisiak

Director/Board Member	11/01/2012	-
Independent Dir/Board Member	11/01/2012	-

Adrian Stimpson

Director/Board Member

05/07/2006

17/01/2011

Darren Nicholls

Director/Board Member	04/06/2012	-
Chief Operating Officer	01/11/2008	29/10/2010
Public Communications Contact	29/10/2010	04/06/2012
President	01/11/2008	-

Jamie Nichols

Corporate Officer/Principal

07/12/2007

Stuart Smith

Director/Board Member

05/12/2007

David R. Hallmen

Director/Board Member	05/12/2007	-
Independent Dir/Board Member	05/12/2007	-

Bijan Sanii

Director/Board Member

05/12/2007

Marc Sandercombe

Director/Board Member

17/01/2007

Craig Schneider

Director/Board Member	10/12/2012	-
Chief Executive Officer	10/12/2012	-
Founder	19/05/1981	-
President	10/12/2012	-

Christopher Bogart

Chief Executive Officer	19/05/1981	-
Founder	19/05/1981	-
Investor Relations Contact	19/05/1981	-

Hyder A. Khoja

Founder

19/05/1981

Intesar Ramley

Director/Board Member	25/11/2002	24/11/2009
Chief Tech/Sci/R&D Officer	24/11/2009	29/10/2010
Founder	19/05/1981	-

Brian Maguire

Chief Operating Officer

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	9
Femme	2

Dont comité exécutif

Homme	6
Femme	1

Dont Administrateurs

Homme	4
Femme	1

InMed Pharmaceuticals Inc. est une société pharmaceutique. La société développe un portefeuille de candidats-médicaments à base de petites molécules ciblant les récepteurs CB1/CB2. Son segment InMed Pharma se consacre à la recherche et au développement de candidats-médicaments à base de petites molécules. Son segment BayMedica Commercial se consacre aux technologies de fabrication permettant de produire et de commercialiser des cannabinoïdes rares en vrac destinés à être vendus comme ingrédients dans le secteur de la santé et du bien-être. Son portefeuille de produits pharmaceutiques comprend trois programmes, avec des candidats-médicaments ciblant la maladie d’Alzheimer, la dégénérescence maculaire liée à l’âge de type sec et l’épidermolyse bulleuse. Son INM-901 est un candidat-médicament en cours de développement en tant que traitement potentiel de la maladie d’Alzheimer. Son INM-089 est un candidat-médicament à petites molécules étudié pour son potentiel en tant que traitement de la dégénérescence maculaire liée à l’âge. Son INM-755 est une crème topique qui a achevé les essais cliniques de phase 2 pour le traitement de l’épidermolyse bulleuse.

Employés

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société